Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science

Launched by COLUMBIA UNIVERSITY · Jul 30, 2009

Keywords

ClinConnect Summary

This clinical trial, titled "Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science," is focused on understanding the genetic factors that may make some people more likely to develop a congenital diaphragmatic hernia (CDH), a condition where a baby is born with an abnormal opening in the diaphragm. The researchers aim to identify specific genes related to this condition, which could help in developing better prevention strategies and treatments in the future. By studying both affected individuals and their families, as well as healthy individuals for comparison, the study hopes to uncover important genetic information that could lead to new insights into CDH.

To be eligible for this trial, participants should either have been diagnosed with a congenital diaphragmatic hernia or have a family history of the condition. Unfortunately, those without a personal or family connection to CDH will not be included. Participants can expect to contribute to important research that could benefit future patients, and they will be part of a diverse group that helps researchers look for genetic differences across various populations. Overall, this study is an exciting opportunity to advance our understanding of congenital diaphragmatic hernia through genetics.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All individuals affected with a congenital diaphragmatic hernia (CDH), or with a family history of a CDH
• Exclusion Criteria:
• • Individuals with no personal history of a CDH or family history of a family member affected with congenital diaphragmatic hernia